Filter
1273
Filtered Results: 1273
Text search:
molecular
testing
Featured
Recommendations
170
New Publications
270
Language
Document type
No document type
610
Guidelines
266
Studies & Reports
218
Manuals
68
Strategic & Response Plan
56
Fact sheets
27
Training Material
14
Situation Updates
9
Resource Platforms
2
Infographics
2
Brochures
1
Countries / Regions
India
80
Western and Central Europe
44
Global
37
Latin America and the Carribbean
32
Africa
29
Kenya
28
Eastern Europe
24
Tanzania
22
South Africa
22
Ethiopia
20
Brazil
18
Germany
16
Nigeria
14
West and Central Africa
14
East and Southern Africa
14
Sierra Leone
13
Malawi
12
Rwanda
11
Uganda
11
Russia
11
Philippines
10
South–East Asia Region
10
Colombia
9
Peru
9
Zambia
9
Indonesia
9
Liberia
9
Nepal
8
Zimbabwe
8
Asia
8
Namibia
8
Mozambique
7
Congo, Democratic Republic of
7
Argentina
7
Bangladesh
6
Myanmar / Burma
6
Ukraine
5
Ghana
5
Syria
5
Senegal
5
USA
5
Middle East and North Africa
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Angola
5
Burkina Faso
4
Ecuador
4
Pakistan
4
El Salvador
3
Chile
3
Cambodia
3
Guinea-Bissau
3
Spain
3
Lebanon
3
Vietnam
3
Botswana
3
South Sudan
3
Eswatini/ Swaziland
3
Tajikistan
2
Lesotho
2
Turkey
2
Benin
2
Cameroon
2
Guinea
2
Italy
2
Venezuela
2
Bolivia
2
Georgia
2
North Macedonia
1
Switzerland
1
Timor Leste/ East Timor
1
Mexico
1
Gambia
1
Afghanistan
1
Haiti
1
Dominican Republic
1
Jordan
1
North America
1
Gabon
1
Turkmenistan
1
France
1
United Kingdom
1
Portugal
1
Latvia
1
Nicaragua
1
Palestine
1
Honduras
1
Iraq
1
Somalia
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
403
Clinical Guidelines
179
Pharmacy & Technologies
53
Public Health
48
Key Resources
23
Women & Child Health
20
Capacity Building
5
Toolboxes
TB
264
COVID-19
173
AMR
107
HIV
85
NTDs
67
Rapid Response
62
Ebola
36
Mental Health
31
Planetary Health
29
Pharmacy
27
Zika
20
Refugee
16
NCDs
14
Polio
12
Specific Hazards
11
Caregiver
6
Cholera
5
Health Financing Toolbox
5
Conflict
5
Natural Hazards
4
Disability
4
Global Health Education
3
Social Ethics
1
Rabies is entirely preventable, and vaccines, medicines, tools and technologies have long
been available to prevent people from dying of dog-mediated rabies. Nevertheless, rabies still
kills about 60 000 people a year, of whom over 40% are children under 15, mainly in rural areas
of economically ...
The desired impact of the OH JPA is a world better able to prevent, predict, detect and
respond to health threats and improve the health of humans, animals, plants and the
environment while contributing to sustainable development. The OH JPA aims to work
towards this vision in the following way:
...
Rabies is a fatal viral zoonosis and serious public health problem.1 All mammals are believed to be susceptible to the disease, and for the purposes of this document, use of the term animal refers to mammals. The disease is an acute, progressive encephalitis caused by viruses in the genus Lyssavirus...
BMJ Open 2021;11:e042279. doi:10.1136/bmjopen-2020-042279. Neglected tropical diseases tend to cluster in the same poor populations, and to make progress with their control, they will have to be dealt with in an integrated manner. Peptide microarrays may be a solution to tese problems, where diagnos...
The publication of the of the Antimicrobial Treatment Guidelines represents the
culmination of the efforts of the Antimicrobial Stewardship Program of ICMR to publish treatment guidelines for common syndromes in India. These guidelines are targeted for the health care settings. It aims to rationali...
Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018. World Health Organization.
В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол...
WHO Ghana 2022 annual report
recommended
“2022 was an eventful year for the WHO Country Office in Ghana,” says Dr Francis Kasolo, WHO Representative to Ghana.
In 2022, WHO Ghana collaborated with partners to deliver interventions in support of the Government of Ghana's health sector agenda to ensure healthy lives for all towards ach...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
This report highlights the work of the World Health Organization (WHO) in Zimbabwe towards contributing to the triple billion targets in the context of the Sustainable Development Goals (SDGs
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
To better adapt current case management practices and address excess mortality in otherwise treatable
cases will require better knowledge of the demographic characteristics of the patients and comorbidities
which can make severe dehydration harder to tolerate physiologically. With this in mind, a ...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy ...
The response to a cholera outbreak must focus on limiting mortality and reducing the spread of the disease. It should be comprehensive and multisectoral, including epidemiology, case management, water, sanitation and hygiene, logistics, community engagement and risk communication. All efforts must b...
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to health facilities or a qualified health care provider and do not receive the necessary care in a...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
This technical report has been developed within the framework of the WHO Global Initiative for
Childhood Cancer. Its goal is to improve the situation of children and adolescents with cancer worldwide,
giving them the best chances of survival, living a full life and, above all, enjoying quality of ...
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are ...
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients wit...
